modaifnil | Modafinil blog
As other categories of medicines, original anti narcoleptic drugs also have their generics. This name means reproduced drug, duration of patent protection for which has already expired. Accordingly to these peculiarities, generic is not the exclusive and real property of the pharmaceutical company that developed and owned of the first license for its sale.
Generics of anti narcoleptic drugs are to be produced, applying the similar technology, using the same source material as the in the production of brands. Usually, generics are to be made after the expiration of the patent of the original, but in some countries, including India, they are manufactured even before the end of the term of a patent’s expiry date. The original drug may have up to some hundred generics.
As for Modafinil, this preparation, as most drugs on the pharmaceutical market, has many generics. The most popular among them are Modavigil, Provigil, Modapro and others drugs.
Generics have the same medicinal properties and peculiarities as they contain the same basic components and ingredients as the brand preparations. Pharmacists recognized the safety of generics. There are no objective reasons for fear: the generic contains the same active drug substance (modafinil) as the original (patented) product. But generics may differ from the brand drugs by inactive ingredients, substances, fillers, preservatives, dyes, etc. Continue reading
Modafinil was created in France in the late 1970s by experimental medicine professor and neurophysiologist Michel Jouvet with support from Lafon Laboratories.
The first manifestation of Modafinil was in a form called Adrafinil, which acts very similarly to how Modafinil works today. Adrafinil was first used experimentally in France in 1986. Modafinil was introduced widely into the French market in 1994, though it is called Modiodal there.
In 1998, the United States Federal Drug Administration (FDA) approved the drug for public use under the name Provigil. The United Kingdom approved the drug for public use in late 2002.
Conditions Treated with Modafinil
Clinical tests have proven that modafinil is helpful for those suffering from narcolepsy, a condition marked by uncontrollable bouts of daytime sleepiness. More health problems that are being treated through recent, experimental uses for Modafinil (Modalert) include:
- Alzheimer’s disease
- Bipolar and unipolar depression
- Parkinson’s disease
Tiredness caused by taking selective serotonin reuptake inhibitors (SSRIs), or antidepressants:
- Attention Deficit Disorder (ADHD)
- Jet lag
- Shift Work Sleep Disorder
- Cancer-associated fatigue
- Impairment of brain function in patients with schizophrenia
Helping lessen the addiction felt by people addicted to cocaine or methamphetamines Studies also are being done on how modafinil can improve many more health conditions, including health problems in the elderly population and those with musculoskeletal disorders, such as muscular dystrophy, who suffer from fatigue.
A standard dose of Modafinil has stimulant qualities that are about the equivalent of three cups of coffee.